The sensitivity of several neurophysiological and cognitive tests to different levels of hypoxia was investigated. Cerebral hypoxia in healthy volunteers may be a disease model for dementia or other forms of brain dysfunction. Twelve healthy subjects were included in a randomized, single-blind, placebo-controlled, three-period cross-over trial. They received three air/N2 gas mixtures via mask breathing [aimed at peripheral oxygen saturation (SPO2) values of > 97% (placebo), 90% and 80%, with normal end-tidal CO2]. Central nervous system effects were tested regularly for 130 min by saccadic and smooth pursuit eye movements, electro-encephalogram, visual analogue scales and cognitive tests. Treatments were well tolerated. Compared to SPO2 90%, SPO2 80% reduced saccadic peak velocity by 16.4 °/s [confidence interval (CI) –26.3, –6.4], increased occipital delta power by 14.3% (CI 3.6, 25.1), and significantly increased most cognitive reaction times. SPO2 80% also decreased correct responses for the binary choice task and serial word recognition [–1.3 (–2.2, –0.3) and –3.5 (–6.2, –0.8), respectively] compared to SPO2 90%. Cognitive performance was decreased by SPO2 80% and increased by SPO2 90% compared to placebo. Sensitive effect measurements can be identified for these interventions. The applicability as a model for cognitive impairment should be investigated further.
Alphers W C J, Aldenkamp A P (1994) FePsy, the iron psyche. Manual 5.0. Publisher, Publisher's Location
2.
Anderson S W, Damasio H, Jones R D, Tranel D (1991) Wisconsin Card Sorting Test performance as a measure of frontal lobe damage. J Clin Exp Neuropsychol13: 909–922
3.
Berry D T, McConnell J W, Phillips B A, Carswell C M, Lamb D G, Prine B C (1989) Isocapnic hypoxemia and neuropsychological functioning. J Clin Exp Neuropsychol11: 241–251
4.
Bond A, Lader M (1976) Self-concepts in anxiety states. Br J Med Psychol49: 275–279
5.
Bonnon M, Noel-Jorand M C, Therme P (1995) Psychological changes during altitude hypoxia. Aviat Space Environ Med66: 330–335
6.
Brown P (1994) Pupil test for Alheimer's. New Sci5-5
7.
Clark C F, Heaton R K, Wiens A N (1983) Neuropsychological functioning after prolonged high altitude exposure in mountaineering. Aviat Space Environ Med54: 202–207
8.
Crow T J, Kelman G R (1971) Effect of mild acute hypoxia on human short-term memory. Br J Anaesth43: 548–552
9.
DeMita M A, Johnson J H (1981) The validity of a computerized visual searching task as an indicator of brain damage. Behav Res Meth Instrument13: 592–594
10.
Denison D M, Ledwith F, Poulton E C (1966) Complex reaction times at simulated cabin altitudes of 5000 feet and 8000 feet. Aerosp Med37: 1010–1013
11.
Ebert U, Kirch W (1998) Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest28: 944–949
12.
Ellis K A, Nathan P J (2001) The pharmacology of human working memoryInt J Neuropsychopharmacol4: 299–313
13.
Endrenyi L, Zha J (1994) Comparative efficiencies of randomized concentration- and dose-controlled clinical trials. Clin Pharmacol Ther56: 331–338
14.
Goldstein G, Welch RB, Rennick PM, Shelly CH (1973) The validity of a visual searching task as an indicator of brain damage. J Consult Clin Psychol41: 434–437
15.
Harron D W, Hasson B, Regan M, McClelland R J, King D J (1995) Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function. J Cardiovasc Pharmacol26 (Suppl.): S48–S54
16.
Jason G W, Pajurkova E M, Lee R G (1989) High-altitude mountaineering and brain function: neuropsychological testing of members of a Mount Everest expedition. Aviat Space Environ Med60: 170–173
17.
Kida M, Imai A (1993) Cognitive performance and event-related brain potentials under simulated high altitudes. J Appl Physiol74: 1735–1741
18.
Kraaier V, Van Huffelen A C, Wieneke G H (1988) Quantitative EEG changes due to hypobaric hypoxia in normal subjects. Electroencephalogr Clin Neurophysiol69: 303–312
19.
Levy G (1994)Pharmacologic target-mediated drug disposition. Clin. Pharmacol. Ther56: 248–252
20.
Nelson R E, Dickson A L, Banos J H (2000) An automated administration of Corsi's block-tapping test. Percept Motor Skills91: 578–580
21.
Noble J, Jones J G, Davis E J (1993) Cognitive function during moderate hypoxaemia. Anaesth Intens Care21: 180–184
22.
Norris H (1971) The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology10: 181–191
23.
Patel S, Tariot P N (1991) Pharmacologic models of Alzheimer's disease. Psychiatr Clin North Am14: 287–308
24.
Regard M, Oelz O, Brugger P, Landis T (1989) Persistent cognitive impairment in climbers after repeated exposure to extreme altitude. Neurology39: 210–213
25.
Saletu B, Grunberger J (1984) The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v. Hum Neurobiol3: 171–181
26.
Saletu B, Grunberger J, Anderer R (1990) On brain protection of codergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies. Int J Clin Pharmacol Ther Toxicol28: 510–524
27.
Saletu B, Anderer P, Paulus E (1991a) EEG brain mapping in diagnostic and therapeutic assessment of dementia. Alzheimer Dis Assoc Disord5: 57–75
28.
Saletu B, Paulus E, Linzmayer L (1991b) Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG ERP mapping study. Psychopharmacology117: 385–395
29.
Saletu B, Anderer P, Fischhof PK, Lorenz H, Barousch R, Bohmer F (1992) EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID. Biol Psychiatry32: 668–681
30.
Schlaepfer T E, Bartsch P, Fisch H U (1992) Paradoxical effects of mild hypoxia and moderate altitude on human visual perception. Clin Sci (Colch)83: 633–636
31.
Sheiner L B (1994) A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data. Clin Pharmacol Ther56: 309–321
32.
Steveninck A L, Berckel B N M, Schoemaker H C, Breimer D D, Gerven J M A, Cohen A F (1999) The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. J Psychopharmacol13: 10–17
33.
Van der Worp H B, Kraaier V, Wieneke G H, Van Huffelen A C (1991) Quantitative EEG during progressive hypocarbia and hypoxia. Hyperventilation-induced EEG changes reconsidered. Electroencephalogr Clin Neurophysiol79: 335–341
34.
van Steveninck A L (1993) Methods of assessment of central nervous system effects of drugs in man thesis. State University, Leiden
35.
van Steveninck A L, Cohen A F, Ward T (1989) A microcomputer based system for recording and analysis of smooth pursuit and saccadic eye movements. Br J Clin Pharmacol27: 712–713
36.
van Steveninck A L, Schoemaker H C, Pieters M S, Kroon R, Breimer D D, Cohen A F (1991) A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers. Clin Pharmacol Ther50: 172–180
37.
van Steveninck A L, Wallnofer A E, Schoemaker R C, Pieters M S, Danhof M, van Gerven J M, Cohen A F (1997) A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population. Br J Clin Pharmacol44: 267–275
38.
Visser S J D, Post V D J, Pieters M S M, Cohen A F, Gerven J M A (2001) Biomarkers for the effects of antipsychotic drugs in healthy volunteers. Br J Clin Pharmacol51: 119–132
